Clinical Trials

Accrual Status
Limit to SWOG Trials

1028 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed SWOG-9249 Intensive Carboplatin/Cyclophosphamide/G-CSF Therapy Followed by Either Standard Dose Paclitaxel (Taxol®) or Intensive Paclitaxel (Taxol®)/G-CSF for Patients with Stage III Suboptimal Disease Ovarian… 3/15/1995 7/1/1998 18%
    Closed SWOG-9300 ATRA/IFN vs ATRA/HU for New CML 10/1/1993 12/1/1999 95%
    Closed SWOG-9304 (INT-0144) RECTAL 3/1/1994 8/1/2000 98% Published
    Closed SWOG-9305 (CALGB-8984) Evaluation of Topotecan in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Phase II 1/15/1994 5/15/1995 75% Published
    Closed SWOG-9307 Extended Administration of Oral Etoposide And Oral Cyclophosphamide for the Treatment of Poor Prognosis Extensive Disease Small Cell Lung Cancer, Phase II Pilot 7/1/1993 6/1/1996 100% Published
    Closed SWOG-9308 Randomized Trial Comparing Cisplatin With Cisplatin Plus Intravenous Navelbine® in the Treatment of Previously Untreated, Stage IV Non-Small Cell Lung Cancer Patients 10/15/1993 6/1/1995 98% Published
    Closed SWOG-9312 Local Bladder 10/1/1993 4/1/1998 100% Published
    Closed SWOG-9313 Phase III Comparison of Adjuvant Chemotherapy with High-Dose Cyclophosphamide plus Doxorubicin (AC) versus Sequential Doxorubicin followed by Cyclophosphamide (A’C) in High-Risk Breast Cancer… 3/15/1994 5/1/1997 98% Published
    Closed SWOG-9314 ER and PgR Predicting Response to Tamoxifen 9/1/1993 12/15/1995 91% Published
    Closed SWOG-9316 Testicular 11/1/1995 10/15/1996 2%
    Closed SWOG-9318 Recombinant Human Erythropoietin (r-HuEPO) as an Adjunct to Radiation Therapy and Cisplatin for Patients with Stages II-B, III and IV-A Carcinoma of the Cervix, Phase II 12/15/1994 3/1/1999 98% Published
    Closed SWOG-9320 AIDS-RELATED: ProMACE-CytaBOM w/trimethoprim sulfa, G-CSF, and antiretroviral therapy (followed by brain RT) 5/1/1994 12/1/2000 100% Published
    Closed SWOG-9321 Previously Untreated MM 1/15/1994 9/15/2000 90% Published
    Closed SWOG-9324 Phase II Trial of Vinorelbine Tartrate (Navelbine®) for Patients with Relapsed Ovarian Cancer 3/15/1995 7/1/1997 100% Published
    Closed SWOG-9326 Phase II Trial of Altretamine for Consolidation of Clinical Complete Response in Patients with Stage III Epithelial Ovarian Cancer 9/1/1993 7/1/1997 100% Published
    Closed SWOG-9327 Randomized Phase II Pilot Study of Pentoxifylline (Trental®) and Placebo in Patients with Metastatic Malignancy and Anorexia/Cachexia Syndrome 2/15/1996 12/15/1997 15%
    Closed SWOG-9328 (ECOG-S9328) Autologous Stem Cell Transplantation for Patients with Acute Myeloid Leukemia Beyond First Remission: A Randomized Trial of Post-Transplant Therapy with Interleukin-2 Versus Observation Phase III 7/1/1994 6/1/1996 4%
    Closed SWOG-9333 Mito/VP-16 vs DNR/Ara-C for Elderly AML 1/15/1995 12/1/1998 84% Published
    Closed SWOG-9338 Advanced Renal 12/15/1994 9/1/1997 100% Published
    Closed SWOG-9339 Evaluation of Topotecan in Esophageal Carcinoma, Phase II 3/1/1994 12/15/1995 100% Published
    Scroll Table